Mistabron in the intensive care unit.
Mistabron is the trade-name of a new mucolytic agent, that has certain advantages over older mucolytic agents. This drug has been used to a great extent in patients with tracheobronchial secretions in the department of intensive care medicine. Its application makes expectoration easier while its preventive administration diminishes greatly the incidence of lung complications.
D006801:Humans; D007362:Intensive Care Units / Q000379:methods*; D008171:Lung Diseases / Q000517:prevention & control; D008623:Mercaptoethanol / Q000031:analogs & derivatives*; D015080:Mesna / Q000008:administration & dosage / Q000627:therapeutic use*
D008623:Mercaptoethanol; D015080:Mesna